Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Single-Center Study to Assess Pharmacokinetics, Safety and Tolerability of KT07 in Healthy Adult Subjects

NCT05223660 is registered in ClinicalTrials.gov with Yiling Pharmaceutical Inc. as lead sponsor.

NCT NCT05223660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05223660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Single-Center Study to Assess Pharmacokinetics, Safety and Tolerability of KT07 in Healthy Adult Subjects
Lead sponsor
Yiling Pharmaceutical Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 7, 2022
Completion date
September 6, 2022
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult subjects, pharmacokinetics, safety and tolerability